View in EDS PDF Full Text

After FIELD: should fibrates be used to prevent cardiovascular disease in diabetes.

Saved in:
Bibliographic Details
Title: After FIELD: should fibrates be used to prevent cardiovascular disease in diabetes.
Authors: Colhoun, Helen
Source: Lancet. 11/26/2005, Vol. 366 Issue 9500, p1829-1831. 3p.
Subjects: Type 2 diabetes, Diabetes, Antilipemic agents, Endocrine diseases, Coronary disease, Lancet, The (Periodical), Medical research
Abstract: The article discusses a FIELD investigators report published in the November 26, 2005 edition of "The Lancet," focusing on the efficacy and safety of 200 mg fenofibrate in preventing CVD in patients with type 2 diabetes. The author reports that there was a non-significant 11% reduction in the primary endpoint of coronary heart disease events, and a significant 11% reduction in total CVD events. The methods used to conduct the study are discusses, as are the participants in the study. It is the author's view that the FIELD is an important study because it allows medical professionals to ask whether fibrates could reasonably replace statins as first choice for primary or secondary prevention of CVD.
Database: Psychology and Behavioral Sciences Collection
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: pbh
DbLabel: Psychology and Behavioral Sciences Collection
An: 18936445
AccessLevel: 6
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: After FIELD: should fibrates be used to prevent cardiovascular disease in diabetes.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Colhoun%2C+Helen%22">Colhoun, Helen</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Lancet%22">Lancet</searchLink>. 11/26/2005, Vol. 366 Issue 9500, p1829-1831. 3p.
– Name: Subject
  Label: Subjects
  Group: Su
  Data: <searchLink fieldCode="DE" term="%22Type+2+diabetes%22">Type 2 diabetes</searchLink><br /><searchLink fieldCode="DE" term="%22Diabetes%22">Diabetes</searchLink><br /><searchLink fieldCode="DE" term="%22Antilipemic+agents%22">Antilipemic agents</searchLink><br /><searchLink fieldCode="DE" term="%22Endocrine+diseases%22">Endocrine diseases</searchLink><br /><searchLink fieldCode="DE" term="%22Coronary+disease%22">Coronary disease</searchLink><br /><searchLink fieldCode="DE" term="%22Lancet%2C+The+%28Periodical%29%22">Lancet, The (Periodical)</searchLink><br /><searchLink fieldCode="DE" term="%22Medical+research%22">Medical research</searchLink>
– Name: Abstract
  Label: Abstract
  Group: Ab
  Data: The article discusses a FIELD investigators report published in the November 26, 2005 edition of "The Lancet," focusing on the efficacy and safety of 200 mg fenofibrate in preventing CVD in patients with type 2 diabetes. The author reports that there was a non-significant 11% reduction in the primary endpoint of coronary heart disease events, and a significant 11% reduction in total CVD events. The methods used to conduct the study are discusses, as are the participants in the study. It is the author's view that the FIELD is an important study because it allows medical professionals to ask whether fibrates could reasonably replace statins as first choice for primary or secondary prevention of CVD.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=pbh&AN=18936445
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/S0140-6736(05)67668-4
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 3
        StartPage: 1829
    Subjects:
      – SubjectFull: Type 2 diabetes
        Type: general
      – SubjectFull: Diabetes
        Type: general
      – SubjectFull: Antilipemic agents
        Type: general
      – SubjectFull: Endocrine diseases
        Type: general
      – SubjectFull: Coronary disease
        Type: general
      – SubjectFull: Lancet, The (Periodical)
        Type: general
      – SubjectFull: Medical research
        Type: general
    Titles:
      – TitleFull: After FIELD: should fibrates be used to prevent cardiovascular disease in diabetes.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Colhoun, Helen
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 26
              M: 11
              Text: 11/26/2005
              Type: published
              Y: 2005
          Identifiers:
            – Type: issn-print
              Value: 01406736
          Numbering:
            – Type: volume
              Value: 366
            – Type: issue
              Value: 9500
          Titles:
            – TitleFull: Lancet
              Type: main
ResultId 1